Real-life quantitative G6PD screening in Plasmodium vivax patients in the Brazilian Amazon: A cost-effectiveness analysis

BACKGROUND: As quantitative glucose 6-phosphate dehydrogenase deficiency (G6PDd) screening tools are evaluated in operational studies, questions remain as to whether they are cost-effective. Here, a cost-effectiveness analysis (CEA) was performed to estimate the Incremental Cost-effectiveness Ratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Brito-Sousa, Jose Diego, Peixoto, Henry M., Devine, Angela, Silva-Neto, Alexandre V., Balieiro, Patricia C. S., Sampaio, Vanderson S., Vitor-Silva, Sheila, Mendes, Maxwell O., Souza, Brenda K. A., Lacerda, Marcus V. G., Monteiro, Wuelton M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982881/
https://www.ncbi.nlm.nih.gov/pubmed/35324892
http://dx.doi.org/10.1371/journal.pntd.0010325

Ejemplares similares

Ejemplares similares